Life Sciences

Established in 2006 as the Life Sciences Corporate Finance arm of Cukierman & Co. Investment House, Cukierman & Co. Life Sciences (CLS) provides investment banking services to private and public companies, at different stages of development, across the whole healthcare spectrum, in Israel, Europe, America and Asia.

CLS mission is to assist biotechnology, pharmaceuticals, diagnostics, medical devices and digital health companies in identifying, negotiating and closing equity and debt financing, licensing agreements, strategic partnerships and M&A transactions; as well as to support venture capital & private equity funds, private investors & family offices, corporate funds & corporate development teams, in selecting, evaluating, acquiring and divesting assets, businesses and companies in all life sciences sectors.

CLS talented team of scientists, finance and business experts, together with our extensive international network, combines product and corporate guidance with global industry knowledge. Whether you are an investor, an entrepreneur or an executive in a large company, we will deliver the most professional investment banking services, including the right financial, scientific, clinical and marketing advice as well as generate creative ideas and sound solutions, in order to implement your strategies for success.


Global access to capital and financing is critical for our clients and counterparties who are looking for efficient private placement, M&A and licensing transactions.

Our offices and integrated networks throughout multiple geographies allows us to access over 2500 investors.
Deal evaluation includes analysis of corporate management, corporate finance, assessment of underlying scientific medical principles, clinical applications, clinical study design, drug and device approval feasibility, intellectual property, commercial application, pricing, reimbursement and analysis of regulatory, legal, and economic changes that affect market dynamics and competitive landscape.


  • Private Placements
  • IPO
  • PIPE
  • M&A financing

Mergers and acquisitions

  • Sell side
  • Buy side
  • Reverse mergers
  • Divestitures

Access to key industry players

Our senior management team and industry networks bring together sector expertise, investment experience, and regulatory, scientific and medical knowledge to emerging healthcare and life science companies, funds and private equity firms.

In recent years, Israel has been at the forefront of bringing major Life Sciences innovations to the market. We offer international groups and VCs access to the Israeli market, helping them to identify and qualify partnerships, investments or acquisition.

  • Strategic R&D partnership
  • In- and out-licensing
  • Asset acquisition and sales
  • Deal strategy, structuring & negotiation
  • Transaction management

related fields of expertise:

  • Company set-up, restructuring and governance
  • Technology, R&D, Patent and Portfolio analysis
  • Regulatory Affairs Strategy and Compliance Services Save
  • Reimbursement and Pricing Services
  • Clinical Research and Clinical Trial Services
  • Licensing, Strategic Partnerships, and Marketing
  • Company valuation modeling and fairness opinion
  • Business plan

Access to our Intelligence Solutions in Life Sciences in partnership with 

Signals provides decision-support solutions based on insights generated from big data on the web using intelligence methodologies and business analytics models to help you make better, faster decisions. Our insights are determined by the best of man and machine: superior automated technology for collection and analysis, and teams of intelligence analysts and subject matter experts.


We provide end-to-end decision support for the product life cycle. Our mission is to be the most trusted partner to the world’s leading companies in providing the highest-quality decision support for our clients’ new product development, product introduction, innovation initiatives, competitive and market intelligence, and exploration of new spaces for growth.


How do we work ?

Based on your mission. As former intelligence officers, we see every one of your business missions as many intelligence questions to be answered, which we solve through our advanced automated search, data collection, and analysis.


Big Data Collection

We cast a wide net for big data to give you the most complete intelligence available. Our sourcing experts identify the best places to uncover the information we need to answer your intelligence questions, from patent listings to trademark databases to the archives of major trade publications; from the websites of your competitors to the social media where your customers chatter about your products. As we work, we focus on being comprehensive, relevant, accurate and timely, to give you the most detailed picture possible of the information you need, on time.


Intelligence Methodologies

Have we mentioned that we are former military intelligence officers and are sticklers for methodology? Traditional intelligence methods guide our work: we believe in looking at information from many different angles.


Analytic Models

We use a mix of traditional and proprietary models for analysis.


Ongoing Support

Signals is your intelligence partner. Our business missions are designed to give you the insights you need to act today and set you up to continue to consume intelligence in an actionable way. This is why Monitoring and Always-On Alerting are key components to so many of our missions – the benefits of intelligence build on one another as you receive real-time updates on all the most significant players in your ecosystem.


Current Assignment

Illustration of International Life Sciences Clients

Selected Transactions

[logooos_saved id=”13485″]


EVENT 2020

Sachs Associates - European HealthTech CEO Forum, 18th February 2020, Zurich, Switzerland
COVID-19 : Cukierman & Co. Life Sciences and GoforIsrael, April 6-7, 2020
COVID-19 Innovation Conference that took place on April 6-7, 2020
Sachs Associates - Digital Novel Coronavirus Investment Forum, 7th - 9th July 2020

Sachs Associates - Digital Novel Coronavirus Investment Forum, 7th - 9th July 2020

EVENT 2019

Go for Israel 2019 Zurich, Switzerland
Held for the first time in Switzerland and dedicated to Life Sciences for the first time, the GoforIsrael Sachs European Life Sciences Conference was a major success with 250 participants including 50 Israeli Life Sciences companies Over 450 1 1 meetings were held during the conference between the Israeli companies and investors from around the world The conference was organized by Cukierman Co Life Sciences and Sachs Associates
Go for Israel 2019 Jinan, CHINA
In our most recent conference in Jinan, China there were 1 400 participants, over 100 Israeli companies, 1 000 Chinese investors and over 800 1 1 meetings The Israeli companies that appeared before the Chinese investors were well established high tech companies alongside young startups all of them received tremendous interest to name just a few of those present Valcare, Curalife, HIL Applied Medical, Nutritional Growth Solutions, MobileODT, Raziel Therapeutics, OCON Healthcare and more
Go for Israel 2019 Tel Aviv, Israel
After the huge success in China and Switzerland, we brought our conference back home, to Israel with an amazing outcome of 1 000 participants including 300 guests from abroad and 100 companies and over 400 1 1 meetings The 23 rd Conference was organised by Cukierman Co Investment House and Catalyst CEL Fund

EVENT 2018

GoForIsrael 2018, March 5th, Tel-Aviv, Israel
Cukierman & Co organizer and sponsor
Sachs Forum, MARCH 6-7th 2017, Zurich, Switzerland
Cukierman & Co Life Sciences partner of the Sachs Forum, Dr. Emmanuel Elalouf panelist at Seed Companies Investor Roundtable
Braintech, March 6-7th 2017, Tel-Aviv, Israel
Dr. Laurent Choppe panelist at Investments in BrainTech
Tech Tour Healthtech Summit, June 21st - 22nd 2016, Lausanne, Switzerland
Cukierman & Co. Life Sciences partner of the TechTour HealthTech Summit, Dr. Laurent Choppe panelist.
SACHS Associates,15th -16th MARCH 2016, Zurich, Switzerland
EUROPEAN LIFE SCIENCE CEO FORUM & EXHIBITION for Partnering and Investing in Biotech & Pharma Industry


■ Life after oil: UAE aiming to tap into Israeli tech to meet future challenges
September 16, 2020
■ Israel third only to U.S. and China in Covid-19 solutions, says life sciences expert
July 17, 2020
■ Interview Dr. Laurent Choppe for Biotech Finances
January 8, 2018
■ Baxter : Ventures invests in Medasense Biometrics
May 23, 2016
■ Israeli Health Tech Is Heating Up With A Wave Of Interest From Abroad
October 25, 2015
■ Interview I24 Dr Laurent Choppe Go4Israel conference
October 17, 2015
■ Chinese investments - the new financing source for Israeli Life Science industry
October 17, 2015
■ Israel Valley article on Green Onyx
February 21, 2015
■ Globes article on Check-Cap IPO
February 19, 2015
■ Xeltis on its fund raising
January, 2015
■ Opsona therapeutics on its fund raising
January, 2015
Skip to content